JPS6237615B2 - - Google Patents

Info

Publication number
JPS6237615B2
JPS6237615B2 JP56029650A JP2965081A JPS6237615B2 JP S6237615 B2 JPS6237615 B2 JP S6237615B2 JP 56029650 A JP56029650 A JP 56029650A JP 2965081 A JP2965081 A JP 2965081A JP S6237615 B2 JPS6237615 B2 JP S6237615B2
Authority
JP
Japan
Prior art keywords
uti
emphysema
pneumonia
solution
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56029650A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57144224A (en
Inventor
Haruo Oonishi
Koji Kojaku
Yasuo Suzuki
Suguru Mochida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Priority to JP56029650A priority Critical patent/JPS57144224A/ja
Priority to PCT/JP1982/000055 priority patent/WO1982003011A1/ja
Priority to DE823235923T priority patent/DE3235923T1/de
Priority to EP82900660A priority patent/EP0073251B1/en
Priority to GB08229371A priority patent/GB2122486B/en
Priority to CA000397353A priority patent/CA1181006A/en
Publication of JPS57144224A publication Critical patent/JPS57144224A/ja
Publication of JPS6237615B2 publication Critical patent/JPS6237615B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP56029650A 1981-03-02 1981-03-02 Remedy for respiratory dieseases Granted JPS57144224A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP56029650A JPS57144224A (en) 1981-03-02 1981-03-02 Remedy for respiratory dieseases
PCT/JP1982/000055 WO1982003011A1 (en) 1981-03-02 1982-03-01 Agent for treating deseases of respiratory organs
DE823235923T DE3235923T1 (de) 1981-03-02 1982-03-01 Therapeutisches mittel zur behandlung von erkrankungen der atemwege
EP82900660A EP0073251B1 (en) 1981-03-02 1982-03-01 Agent for treating diseases of respiratory organs
GB08229371A GB2122486B (en) 1981-03-02 1982-03-01 Agent for treating diseases or respiratory organs
CA000397353A CA1181006A (en) 1981-03-02 1982-03-01 Therapeutic agent for treating respiratory diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56029650A JPS57144224A (en) 1981-03-02 1981-03-02 Remedy for respiratory dieseases

Publications (2)

Publication Number Publication Date
JPS57144224A JPS57144224A (en) 1982-09-06
JPS6237615B2 true JPS6237615B2 (en]) 1987-08-13

Family

ID=12281975

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56029650A Granted JPS57144224A (en) 1981-03-02 1981-03-02 Remedy for respiratory dieseases

Country Status (6)

Country Link
EP (1) EP0073251B1 (en])
JP (1) JPS57144224A (en])
CA (1) CA1181006A (en])
DE (1) DE3235923T1 (en])
GB (1) GB2122486B (en])
WO (1) WO1982003011A1 (en])

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100964A3 (de) * 1982-07-31 1984-06-13 Reifenrath, Rainer, Dr. Pharmazeutisches Erzeugnis zur Behandlung und Prophylaxe von Infektionen sowie von Husten und obstruktiven Atemwegserkrankungen sowie Verfahren zu seiner Herstellung
JPS6137736A (ja) * 1984-07-31 1986-02-22 Nippon Chem Res Kk 人尿トリプシンインヒビタ−製剤の製法
FI854634A0 (fi) * 1985-11-22 1985-11-22 Labsystems Oy Foerfarande foer bestaemning av proteolytisk aktivitet.
EP0255011A3 (en) * 1986-07-29 1988-11-23 Miles Inc. Human inter-alpha-trypsin inhibitor gene
JP2656944B2 (ja) * 1987-04-30 1997-09-24 クーパー ラボラトリーズ タンパク質性治療剤のエアロゾール化
JP2804979B2 (ja) * 1988-11-28 1998-09-30 日本ケミカルリサーチ株式会社 エイズ治療および阻害剤
CA2055425A1 (en) * 1990-11-13 1992-05-14 Hideaki Morishita Polypeptide, dna fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same
CA2082226A1 (en) * 1991-11-08 1993-05-09 Hideaki Morishita Polypeptide, dna fragment encoding the same, drug composition containing the same and process for producing the same
US5650394A (en) * 1993-11-04 1997-07-22 Adeza Biomedical Use of urinastatin-like compounds to prevent premature delivery
KR101036058B1 (ko) * 2002-04-25 2011-05-19 더 스크립스 리서치 인스티튜트 폐질환 증상의 치료 및 예방
GB0507577D0 (en) * 2005-04-14 2005-05-18 Novartis Ag Organic compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57140728A (en) * 1981-02-26 1982-08-31 Mochida Pharmaceut Co Ltd Decomposition product of substance inhibiting trypsin in urine

Also Published As

Publication number Publication date
DE3235923T1 (de) 1983-02-24
WO1982003011A1 (en) 1982-09-16
EP0073251A1 (en) 1983-03-09
CA1181006A (en) 1985-01-15
EP0073251A4 (en) 1983-07-08
JPS57144224A (en) 1982-09-06
EP0073251B1 (en) 1986-06-11
GB2122486B (en) 1985-02-27
DE3235923C2 (en]) 1988-05-26
GB2122486A (en) 1984-01-18

Similar Documents

Publication Publication Date Title
US4636489A (en) Modified protease inhibitors, process for their preparation, and pharmaceutical compositions prepared therefrom
US20040018190A1 (en) Drugs and foods improving the quality of life and process for producing the same
US5008242A (en) Treatment of inflammation using 1-antichymotrypsin
US4916117A (en) Treatment of inflammation using alpha 1-antichymotrypsin
JPS6237615B2 (en])
US6413512B1 (en) Composition and method for treating disease by increasing activated α2 macroglobulin in the blood and extravascular tissue
CN118285504B (zh) 具有菌源二肽基肽酶-4抑制活性的植物提取物及其应用
JPH0710772A (ja) 炎症性浮腫亢進抑制剤
JPH0521092B2 (en])
JP4006058B2 (ja) 多臓器不全予防及び／又は治療剤
JPH0148249B2 (en])
JPH029600B2 (en])
PT101135A (pt) Composicoes farmaceuticas contendo proteinas ou susbtancias peptidicas que intesificam a biodisponibilidade de agentes terapeuticos proteoliticamente labeis
JPH09241157A (ja) リソスペルメートｂ含有肝臓保護作用医薬組成物
Holms et al. Ezrin Peptide Therapy: A Potential Treatment for COVID
US20030007959A1 (en) Oral methods of treatment
JPH08109140A (ja) 高血圧症予防治療剤
JPH08782B2 (ja) 抗炎症剤
JPH07507289A (ja) 抗炎症剤
JPS60161925A (ja) 安定なカリジノゲナーゼ打錠製剤の製法
JPH01203334A (ja) 白金を含有する薬剤の副作用軽減剤
EP0753309A2 (en) Preparation of lactoferrin (or analogous proteins) and desferrioxamine methanesulfonate (or other metal ion chelators) for the therapy of viral infectious diseases
JP2001335503A (ja) ラジカル消去用医薬品
JPS58225026A (ja) アミラ−ゼ活性および／またはリパ−ゼ活性亢進に起因する疾患の予防および治療剤
Moshal Nutrizym as a pancreatic enzyme replacement